Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year research collaboration agreement with Merck, known as ...
After generating interest from the likes of Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted ...
High-sensitivity sequencing of recurrent, cell-type–specific variants aims to strengthen causal inference versus germline ...
MSD is paying $20 million upfront to activate an alliance with Flagship Pioneering's Quotient Therapeutics that will focus on ...
Cambridge-based Flagship spinout Quotient Therapeutics has locked in a potential $2.2 billion research partnership with Merck ...
In today's Pharmaceutical Executive Daily, Bayer shares briefly dip after activist investor Inclusive Capital offloads its ...
Quotient, which originated as the consumer-facing Coupons.com in the late ’90s, is pushing deeper into programmatic media. The company has launched the Quotient Media Exchange (QMX), a digital media ...
Offering of 2500+ Buyer Ready Segments Represents New Standard in Digital Audience Solutions Designed to Enable More Effective and Measurable Digital Advertising That Converts to Sales MOUNTAIN VIEW, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results